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Abstract 33 
Within the Process Analytical Technology (PAT) framework, it is of utmost importance to obtain 34 
critical process and formulation information during pharmaceutical processing. Process analyzers are 35 
the essential PAT tools for real-time process monitoring and control as they supply the data from 36 
which relevant process and product information and conclusions are to be extracted. Since the last 37 
decade, near infrared (NIR) and Raman spectroscopy have been increasingly used for real-time 38 
measurements of critical process and product attributes, as these techniques allow rapid and 39 
nondestructive measurements without sample preparations. Furthermore, both techniques provide 40 
chemical and physical information leading to increased process understanding. Probes coupled to the 41 
spectrometers by fiber optic cables can be implemented directly into the process streams allowing 42 
continuous in-process measurements. This paper aims at reviewing the use of Raman and NIR 43 
spectroscopy in the PAT setting, i.e. during processing, with special emphasis in pharmaceutics and 44 
dosage forms. 45 
 46 
 47 
 48 
 49 
50 
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1. Introduction 51 
 52 
The Food and Drug Administration’s (FDA) Process Analytical Technology (PAT) initiative (FDA, 2004) 53 
forms the basis of the pharmaceutical Good Manufacturing Practice (GMP) rules for the 21st century 54 
(Hinz, 2006). Because the pharmaceutical industry is highly regulated, final products must meet very 55 
stringent specifications. However, this does not mean that pharmaceutical processes are optimized. 56 
Conventional pharmaceutical manufacturing is generally accomplished using batch processing with 57 
off-line time-consuming and less efficient laboratory testing conducted on randomly collected 58 
samples to evaluate quality. The processes themselves are not fully understood and are often 59 
inefficient black-boxes. Limited relevant information is mainly obtained after the process, making 60 
process control difficult which can result in batch losses. The ultimate goal of PAT is a better 61 
fundamental scientific understanding of manufacturing processes (i.e., the process should not be a 62 
black box system). One of the most important statements within the PAT concept is that ‘quality 63 
should not be tested into products; it should be built in’. PAT should therefore play a crucial role in 64 
design, analysis, and control of manufacturing processes based on timely in-line, on-line and at-line 65 
measurements (i.e., during processing) of critical quality and performance attributes of raw and in-66 
process materials, with the goal of ensuring final product quality (EUFEPS QbD and PAT Sciences 67 
Network, 2010). It is thus aimed to obtain real-time information of all critical process aspects and to 68 
guide processes towards their desired state, hence ensuring the quality of each end product and 69 
possibly allowing real-time release. Continuous gathering of critical process information during 70 
production should allow real-time process adjustments to keep product specifications within 71 
predefined limits, hence avoiding batch loss. For a long time, innovations in pharmaceutical 72 
manufacturing and quality assurance have been slowed down by the stringent regulatory constraints 73 
within the pharmaceutical industry which allowed little room for change and which significantly 74 
contributed to the aversion to bring new manufacturing technologies and quality assurance methods 75 
to the attention of the regulators (in order to avoid delaying regulatory approval). The PAT initiative 76 
to move towards a risk- and science based approach for pharmaceutical processing is now strongly 77 
encouraged by the most important pharmaceutical regulatory authorities (e.g., FDA and the 78 
European Medicines Agency, EMA). 79 
Process analyzers are the essential PAT tools for real-time process monitoring and control as they 80 
supply the data from which relevant process and product information and conclusions are to be 81 
extracted. Available tools have evolved from those that predominantly take univariate process 82 
measurements, such as pH, temperature, and pressure, to those that provide multivariate 83 
information related to biological, physical, and chemical attributes of the materials being processed 84 
(e.g., Raman and NIR spectrometers). In a PAT environment, real-time process measurements can be 85 
- at-line: measurements where the sample is removed, isolated from, and analyzed in close 86 
proximity to the process stream. 87 
- on-line: measurements where the sample is diverted from the manufacturing process, and 88 
may be returned to the process stream. 89 
- in-line: measurements (invasive or noninvasive) where the sample is not removed from the 90 
process stream [FDA, 2004]. 91 
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The following aspects should be considered when implementing process analyzers into process 92 
streams: 93 
- selection of a suitable process analyzer or combination of complementary process analyzers 94 
able to monitor the desired critical process and product information, 95 
- determination of the locations in the process streams where and how process analyzers 96 
should be and can be implemented to monitor the required information, 97 
- determination of the optimal measurement conditions for the process analyzer to obtain 98 
useful data, 99 
- validation of the performance of process stream analyzers (over time). 100 
Since the last decade, near infrared (NIR) and Raman spectroscopy have been increasingly used for 101 
real-time measurements of critical process and product attributes during pharmaceutical processing, 102 
as these spectroscopic techniques allow rapid and nondestructive measurements without sample 103 
preparations. Furthermore, probes coupled to the spectrometers by fiber optic cables can be 104 
implemented directly into the process streams allowing continuous real-time in-process 105 
measurements. A quick search in Web of Sciences® shows the strongly increased number of 106 
publications during the last decade about the use of Raman and/or NIR for pharmaceutical in-process 107 
measurements. Besides the practical advantages, an important reason for the high interest for 108 
Raman and NIR spectroscopy as process analyzers is their ability to supply versatile and multivariate 109 
information. One single spectrum may contain qualitative and quantitative physical and chemical 110 
information. 111 
This paper aims at reviewing the use of Raman and NIR spectroscopy in the PAT setting, i.e. during 112 
processing, with special emphasis in pharmaceutics and dosage forms. Hence, there will be focused 113 
on applications where NIR and Raman spectroscopy have been used in-line, at-line and on-line to 114 
monitor and control pharmaceutical production processes in real-time. Many studies have been 115 
performed using Raman and/or NIR spectroscopy as off-line tools for chemical and physical analysis 116 
of pharmaceuticals (e.g., API quantification in tables, co-crystal screening, etc.). Evidently, these 117 
studies also contribute to the increased understanding of the production of pharmaceuticals. Several 118 
reviews describe and evaluate these off-line Raman and NIR applications (Aaltonen et al., 2008; 119 
Aaltonen et al., 2009; Fevotte, 2007; Heinz et al., 2009; Luypaert et al., 2007; McGoverin et al., 2008; 120 
Pinzaru et al., 2004; Radtke et al., 1999; Rasanen and Sandler, 2007; Reich, 2005; Strachan et al., 121 
2007; Tantipolphan et al., 2008; Tummala et al., 2005; Wen, 2007; Yu et al., 2007).  122 
2. NIR versus Raman spectroscopy 123 
NIR and Raman spectroscopy are both molecular vibrational spectroscopic techniques studying 124 
vibrational transitions in molecules.  125 
2.1. Raman spectroscopy 126 
The Raman effect was first observed in 1928 by Sir C.V. Raman (Raman and Krishnan, 1928). 127 
However, this effect was already predicted in 1923 by Smekal, based on theoretical calculations 128 
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(Smekal, 1923). The Raman effect is the inelastic scattering of electromagnetic radiation (EMR) as a 129 
result of energy exchange between the radiation and molecular vibrations. The theoretical 130 
background of the Raman effect is well described in literature (Gardiner, 1989; Long, 1977; 131 
Nakamoto, 1986; Stoicheff, 1959). 132 
In Raman spectroscopy, the samples are irradiated with monochromatic laser light. Typically, lasers 133 
producing laser light in the visible (e.g. 532 nm) or near-infrared (e.g. 785 nm and 1064 nm) range 134 
are used. The energy of this light is higher than the energy needed to bring molecules to a higher 135 
vibrational state (Figure 1). Most of the incident radiation is scattered by the sample molecules at the 136 
same frequency (= energy). This identical scattered light is called Raleigh radiation. Only 10-8 is 137 
scattered inelastically by the sample molecules, indicating that energy exchange occurred between 138 
the incident light and the sample. This inelastic scattering is called the Raman effect. This inelastic 139 
scattered radiation can have a lower energy (lower frequency) than the incident radiation or a higher 140 
energy (higher frequency) than the incident radiation. The first type of inelastic scattering is called 141 
Stokes radiation, the latter anti-Stokes radiation (Figure 1). At room temperature, mainly Stokes 142 
radiation will occur. At high temperatures (e.g., 500°C), many sample molecules are already at a 143 
higher vibrational state as can be derived from the Boltzmann distribution, hence favoring anti-144 
Stokes radiation.  145 
The selection rule for molecules to be Raman active is that a change in polarizability of the molecule 146 
occurs during its normal modes. The polarizability of a molecule is the ease with which the electron 147 
cloud of a molecule can be distorted after bringing the molecule in an electromagnetic field (i.e., by 148 
light irradiation). However, molecules are no static entities, but continuously in motion by vibrations, 149 
rotations and translations. The actual vibration of a molecule seems arbitrary, but is in fact the 150 
superposition of some simple vibration modes, called normal modes. Each of these normal modes 151 
has its own frequency. An atom has 3 degrees of freedom (x, y and z direction). Hence, a molecule 152 
containing N atoms has 3N degrees of freedom: 3 translations, 3 rotations (2 for a linear molecule) 153 
and 3N-6 normal modes (3N-5 for linear molecules). For a diatomic molecule, e.g., the ease to distort 154 
the electron cloud will be different for the three vibration states of its harmonic vibration having 155 
frequency νv, as schematically shown in figure 2a. The larger the bond distance, the further the 156 
electrons are apart from the nuclei an thus the easier they can be moved. This change in ease with 157 
which the electron cloud of a molecule can be distorted (i.e.; change in polarizability) is needed for 158 
Raman activity. Complicated quantum mechanics and the group theory are needed to determine for 159 
which of the normal modes of complex molecules a change in polarizability occurs. 160 
A Raman spectrum displays the frequency difference between the incident radiation and the 161 
scattered radiation, expressed as wavenumbers, versus the intensity (I) of the scattered radiation 162 
(Figure 3). Placzek developed the following equation which allows the calculation of the Raman 163 
intensity during a particular vibration: 164 
 165 
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where: 0v  is the frequency of the incident radiation 167 
  vv is the vibration frequency of the molecule 168 
  N is the number of irradiated Raman active molecules 169 
  0I is the power of the light source 170 
  h is Planck’s constant (= 6.6260.10-34 Js) 171 
  k is the Boltzman’s constant 172 
  T is the temperature 173 
  Sα is the polarizability from the molecules causing Stokes radiation 174 
  aα is the polarizability from the molecules causing anti-Stokes radiation. 175 
However, besides these parameters the Raman intensity is also determined by instrumental (e.g., 176 
detector, length of glass fiber when using probes, etc.) and sample parameters (e.g., sampling 177 
volume, sample particle size, refractive index of sample, concentration of the considered compound, 178 
etc.). Furthermore, as scattering occurs in all directions, only a fraction is detected. When probes are 179 
implemented into process streams, only the light which is scattered into the same direction as where 180 
the incident light comes from is measured.  181 
The irradiation of materials can result in different phenomena: scattering, absorption and 182 
fluorescence. As the Raman effect is inherently weak, the other phenomena can interfere strongly. 183 
Moreover, heating, photodecomposition and laser ablation can occur. The incident laser light can be 184 
absorbed when the wavelength of this light corresponds with the absorption band in the spectrum of 185 
the molecule, resulting in the transition of the molecule to the excited state (dependent of the laser 186 
to the excited vibrational or electronic state). The absorbed energy is then transformed via 187 
radiationless transitions into thermic energy. This absorption interferes quite strongly with the 188 
Raman effect as the intensity of Raman scattering is proportional to the intensity of the laser light. 189 
This interference can be avoided by using another wavelength laser. Besides the absorption of the 190 
laser light, absorption of the scattered light can likewise occur. Fluorescence can produce substantial 191 
interferences in Raman spectroscopy when the molecule is excited to an electronic excited state. The 192 
molecule decays to a lower energy level by a radiation-less transition (the vibrational ground state in 193 
the electronic excited state), followed by the decay to the electronic ground state (Figure 1). During 194 
this last decay, fluorescent radiation is emitted, interfering with the Raman signal. Interference by 195 
fluorescence can be avoided employing lasers with other (higher) wavelengths to make sure that no 196 
excitation to the electronic excited state occurs. As the intensity of the Raman signal is proportional 197 
to the intensity from the laser upon the sample, it is favorable to use as high as possible laser 198 
intensities. However, destructive effects can occur by high energy supply. Absorption of radiation 199 
with insufficient energy transfer to the surroundings results in sample heating (and possibly 200 
destruction). Laser ablation is a phenomenon where material is removed from the sample. Several 201 
effects occur simultaneously: photodecomposition, thermic expansion and decomposition. 202 
Furthermore, a mechanic effect occurs by a mechanic power of the laser radiation on the sample. 203 
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When the energy added to the sample per time unit is larger than the bond energy and when the 204 
energy is dissipated, ablation occurs resulting in a crater (Gardiner, 1989; Long, 1977; McCreery, 205 
2000,Nakamoto, 1986; Stoicheff, 1959);  206 
 207 
2.2. NIR spectroscopy 208 
 209 
The discovery of NIR energy is ascribed to Herschel in the 19th century (Herschel, 1800), but the first 210 
industrial applications only appeared in the 1950s. NIR spectroscopy studies the absorption of EMR in 211 
the NIR region, i.e. 700 nm - 2500 nm (14300 cm-1 – 4000 cm-1). Mid infrared and Far infrared light 212 
can be situated in the 2500 nm – 10000 nm and 10 µm – 1000 µm range, respectively. The basic 213 
principles of NIR spectroscopy are thoroughly described in a review from Reich, 2005. The detailed 214 
theory of NIR spectroscopy can be found in Williams & Norris 1987, Osborne et al 1993, Blanco et al 215 
1998, Chalmers & Griffiths 2002 and Ciurczak & Drennen 2002. 216 
 217 
In NIR spectroscopy, the samples are irradiated with NIR light. Some of this NIR light is absorbed by 218 
the molecules, bringing them to a higher vibrational state (Figure 1). Common incandescent or quartz 219 
halogen light bulbs are most often used as broadband sources of NIR radiation for analytical 220 
applications. Light-emitting diodes (LEDs) are also used and offer greater lifetime and spectral 221 
stability and reduced power requirements. Only vibrations resulting in changes in dipole moment of a 222 
molecule can absorb NIR radiation. A dipole is the product of charge (positive and negative) and 223 
distance. Figure 2b shows that there is no change in dipole moment during the stretch vibration of an 224 
X2 molecule. Figure 2c shows that there is a change in dipole moment during the stretch vibration of 225 
an XY molecule (Visser, 1980). Two-atomic molecules require a permanent dipole to be IR active, 226 
while moreatomic molecules only require a dipole induced by the vibration. R-H groups have the 227 
strongest overtones as the dipole moment is high. Also O-H, N-H, C-H, S-H bonds are therefore strong 228 
NIR absorbers. H2 does not absorb NIR radiation as no change in dipole moment occurs during its 229 
vibrations. Molecules that absorb NIR energy vibrate in 2 modes: stretching and bending. Stretching 230 
is defined as a continuous change in the interatomic distance along the axis of the bond between two 231 
atoms. Bending is defined as a change in bond angle. A C-H stretch for example will have a 232 
fundamental absorption band near 2960 cm-1. The 1st and 2nd C-H stretch overtone will hence occur 233 
near 5920 cm-1 and 8880 cm-1, respectively. A C-H combination will occur near 4420 cm-1, which is the 234 
sum of a C-H stretch (2960 cm-1) and a C-H bend (1460 cm-1). Figure 4 shows an example of an NIR 235 
spectrum. 236 
 237 
Figure 2a shows 3 possible vibration states of a diatomic molecule. The potential energy of these 238 
vibrations is dependent on the bond length as can be seen in figure 5, representing an anharmonic 239 
vibration model. At equilibrium, the potential energy is low. Bringing the atoms closer to each other 240 
induces repulsion, resulting in an increase in potential energy. Pulling the atoms away from each 241 
other in first instance leads to attraction, resulting in an increased potential energy. However, 242 
bringing the atoms far enough from each other does not result in further increase of potential 243 
energy. Further displacement of the atoms will result in dissociation. However, from the quantum 244 
theory, only some vibrational energy levels are allowed, respresented by the horizontal lines in figure 245 
5. These energy levels are not equidistant in an anharmonic model. An NIR spectrum contains 246 
overtones and combinations derived from fundamentals which appear in the IR region. 247 
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The low molar absorptivity of absorption bands in the NIR region permits the operation in the 248 
reflection mode. Hence, spectra can be recorded with minimal or no sample preparations. In the 249 
reflection mode, the light reflected by the sample surface (i.e., the non-absorbed light) is measured 250 
(Räsänen et al., 2007).  251 
2.3. Raman and NIR spectroscopy 252 
Raman and NIR spectroscopic measurements can both be done in a very fast (seconds) and non-253 
destructive way, making both tools suited for real-time process monitoring. Custom made fiber optic 254 
probes connected to the spectrometers can be implemented into process streams. Referring to the 255 
different selection rules for Raman and NIR activity (change in polarizability and change in dipole 256 
moment, respectively), both vibrational techniques can be complementary. Molecules producing 257 
good signals in NIR spectra might produce weak signals in Raman spectra and vice versa. Raman and 258 
NIR spectra contain qualitative and quantitative information on the chemical composition and the 259 
physical properties (e.g., particle surface, particle size and shape distribution) of the measured 260 
sample (Ciurczak et al., 1986; Osborne et al., 1993; Pellow-Jarman et al., 1996; Rantanen & Yliruusi, 261 
1998; Wang et al., 2002; Hu et al., 2006). 262 
Raman and NIR spectroscopic monitoring of pharmaceutical processes typically result in a huge 263 
amount of spectral data. Chemometric techniques are obvious to explain the variation in the data 264 
and to extract useful process information leading to process understanding and process conclusions. 265 
Spectral pretreatment before chemometric analysis is often desired to reduce the effect of 266 
interfering variance in which one is not interested, thereby increasing the part of the variance due to 267 
parameters of interest (Luypaert et al., 2004). Adequate spectral preprocessing is hence very critical 268 
for further chemometric data-analysis and data-interpretation (Rinnan, 2009). 269 
3. In-process monitoring using Raman and NIR spectroscopy 270 
During the manufacturing process of solid dosage forms, the active pharmaceutical ingredients and 271 
excipients are subjected to several consecutive process steps: synthesis, crystallization, milling, 272 
blending, granulation, drying, tableting, coating and packing. Evidently, as not only tablets are 273 
produced, also other widely applied unit operations will be reviewed (e.g., extrusion-sferonisation, 274 
freeze-drying, etc.). Within the scope of increased process efficiency and increased production, there 275 
is the intention within the pharmaceutical industry to move from traditional batch processing to 276 
continuous processing (Vervaet and Remon, 2005). Continuous production processes are based on 277 
the ‘one-in-one-out’ principle, and avoid scale-up issues, reduce cycle times, reduce production 278 
costs, ensure faster product release, reduce variability, increase flexibility and efficiency, and 279 
improve product quality. It is obvious that the current conventional quality control systems of 280 
production processes, based on mainly off-line analyses in analytical laboratories, would annul the 281 
advantages of continuous processing, and that continuous real-time quality control is indispensable 282 
for continuous production. The desire within the pharmaceutical industry to shift towards continuous 283 
processing strengthens the desire and need to invest in PAT. This review mainly focuses on the 284 
applicability of Raman and NIR spectroscopy for in-process analysis during the production of solid 285 
dosage forms. The use of Raman and NIR spectroscopy for the in-process monitoring of drug 286 
synthesis processes and crystallization processes is evaluated in Rantanen (2007) and Räsänen and 287 
Sandler (2007). 288 
9 
 
Process analysers are the essential PAT tools for real-time process monitoring and control (in-line, 289 
on-line or at-line) as they supply the data from which relevant process and product information and 290 
conclusions are to be extracted. The following steps should be applied to implement process 291 
analyzers in process streams: 292 
- Determination of all required critical information. In order to determine crucial and relevant 293 
information (e.g., process step endpoints, intermediate or end product quality 294 
requirements), as much as possible pharmaceutical technological knowledge should be 295 
gathered from the available literature and in-house process knowledge. It is essential to 296 
know which intermediate process step endpoints have to be reached and which required 297 
intermediate quality attributes should be obtained before the next process step can start. 298 
The relevant quality parameters should be defined. 299 
- Selection of the suited process analyzer or combination of complementary process analyzers 300 
able to supply the required critical information. 301 
- Determination of the locations in the process streams where process analyzers should be and 302 
can be implemented. 303 
- Determination of optimal process analyzer measurement conditions to obtain useful data. 304 
Rantanen (2007) clearly described the challenges in process analysis with Raman spectroscopy and 305 
discussed several approaches to overcome them (Figure 6). Similar challenges and solutions are 306 
observed and valid for in-process NIR spectroscopy.  307 
Table 1 shows an overview of many publications in which the use of Raman and NIR spectroscopy for 308 
in-process monitoring of pharmaceutical unit operations has been evaluated. For each of these 309 
studies the in-process interfacing of the spectroscopic tool, the monitored information, the discussed 310 
challenges and the applied spectral preprocessing and data-analysis methods are specified.  311 
3.1. Blending 312 
Blending is a critical unit operation of the production process of many solid dosage forms. The quality 313 
of products depends on the degree of mixing of their constituents, which guarantees the 314 
homogeneity of the final product. Mendez et al., 2010 recently proposed a simple and practical 315 
operational qualification procedure to investigate the pharmaceutical mixing operation on a large 316 
scale. Compared to NIR, the use of Raman spectroscopy for the in-line monitoring of pharmaceutical 317 
blending processes has been less described in literature. Vergote et al. (2004) used Raman 318 
spectroscopy for the in-line monitoring of the blending process of a binary mixture (50/50, w/w) of 319 
diltiazem pellets and paraffinic wax beads (particle size: 800 – 1200 µm). The mixing bowl contained 320 
a glass window in front of which a fiber optic non-contact probe was placed. The mean square of 321 
differences (MSD) between two consecutive collected spectra was used to identify the endpoint of 322 
mixing (i.e., homogeneity). Once homogeneity is obtained, the spectra remain constant resulting in 323 
an MSD of zero. Wikström et al. (2005) investigated the importance of the Raman spectrometer 324 
sampling optics regarding the assessment of powder mixture homogeneity. They found that large 325 
spot non-contact optics (spot size 3 mm instead of 60 µm) provide significant advantages because of 326 
the enhanced sampling volume and the greater robustness to fluctuations in sampling distance 327 
during processing. Rantanen et al. (2005a) also found that the sample volume seriously affected the 328 
performance of calibration models for the quantification of anhydrate/hydrate powder mixtures 329 
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using Raman and NIR spectroscopy. The calibrations were significantly improved using larger 330 
sampling areas. Furthermore, the authors showed that multivariate regression not always improves 331 
the predictability of the data compared to univariate analysis. As mentioned in 2.1., the detection 332 
sensitivity of Raman spectroscopy is rather low. Hence, there lays an important challenge in the in-333 
line monitoring of low dose blend uniformity. Hausman et al. (2005) showed the ability of Raman 334 
spectroscopy to determine the endpoint of the blending process of a low dose, 1%, azimilide 335 
dihydrochloride formulation. However, it should be emphasized that low dose detection is very 336 
formulation dependent and strongly depends on the Raman activity of API and excipients. De Beer at 337 
al. (2008) presented a Soft Independent Modelling of Class Analogy (SIMCA) model allowing the 338 
determination of the homogeneity of blends in-line and real-time using Raman spectroscopy in 339 
combination with a fiber optical immersion probe.  340 
As water is a weak Raman scatterer, Raman spectroscopy presents itself as a suitable tool for 341 
measurements in aqueous environments. De Beer et al. (2006) showed the ability of Raman 342 
spectroscopy to monitor in-line the homogenization process of an aqueous pharmaceutical 343 
suspension. At the same, time it was possible to quantify the API concentration in the suspension. 344 
NIR applications assessing powder blend homogeneity are numerous. Hailey et al. (1996) 345 
demonstrated the interfacing of NIR with a blender. Complete supervisory control and data analysis 346 
(SCADA) software controlled the blender and spectrometer operation and performed statistical 347 
spectral data analysis in real-time. Sekulic et al. (1998) studied the effect of different preprocessing 348 
approaches (detrending, standard normal variates (SNV), second derivatives, and the combination of 349 
detrending and standard normal variates) on NIR spectra collected in-line during powder blending. 350 
Depending on the purpose of the application, the user may or may not be interested in the spectral 351 
contributions originating from the physical characteristics of the sample. Where these characteristics 352 
are important, the user may choose to work with the raw spectral data, otherwise some pre-353 
treatment or preprocessing is usually carried out. Furthermore, the authors evaluated several 354 
algorithms used to determine blend homogeneity (mean standard deviation versus blend time, 355 
moving block standard deviation, dissimilarity calculations, principal component analysis (PCA) and 356 
SIMCA). These blend profiling approaches did not show any appreciable differences in this study. El-357 
Hagrasy et al. (2001) used NIR spectroscopy noninvasively to monitor powder blend homogeneity. 358 
They showed that multiple sampling points are needed for accurate and precise estimation of mixing 359 
endpoint. Therefore, six sapphire windows were mounted at different locations on the V-blender 360 
through which NIR spectra were collected. Shi et al. (2008) showed that the blending behavior at two 361 
sensor locations demonstrated a significant difference for endpoint and blending variability. In 362 
another study El-Hagrasy et al. (2006a) used a design of experiments approach to identify the critical 363 
factors affecting powder blending. The effect of humidity, component concentration and blender 364 
speed was evaluated on mixing endpoint, particle size and density of powder. All these variables 365 
were shown to have a significant effect on the blending endpoint. Moreover, humidity and 366 
concentration had a significant effect on particle size and powder density. NIR spectroscopy showed 367 
to be sensitive to changes in physicochemical properties of the mixtures. The authors found that 2nd 368 
derivative spectral preprocessing was suitable to minimize the spectral variations due to changes in 369 
physical properties, while monitoring chemical changes. In another study,  El-Hagrasy et al. (2006b) 370 
developed two pattern recognition models (SIMCA and Principal Component Modified Bootstrap 371 
Error-adjusted Single-sample Technique, PC-MBEST) combined with 2nd derivative preprocessing on 372 
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the spectra, allowing to predict the blend homogeneity of independent blend samples manufactured 373 
under different processing conditions (humidity, blender speed, component concentration). Barajas 374 
et al. (2007) developed an NIR spectroscopic method for the monitoring of flowing pharmaceutical 375 
powders during their voiding and for the detection of post-blending segregation. Particle size 376 
differences in powder blends are known as driver for segregation. Zhang et al. (2009) developed a 377 
new blending endpoint determination method. A hidden Markov model showed to have a better 378 
reliability, a higher robustness and a more transparent endpoint decision making compared to the 379 
traditionally MBSD method. Ufret and Morris (2001), used NIR spectroscopy throughout blending 380 
runs to obtain the mixing profile and the dynamics of the powder bed as function of the blender 381 
rotations. This approach elucidated the existing relationship between the characteristic mixing 382 
parameters (e.g., formulation ingredients, geometry of the mixer, batch load) and the required 383 
rotations to achieve content uniformity. Bellamy et al. (2008) studied the effects of particle size and 384 
cohesive properties on mixing with non-contact NIR. They found that the magnitude of the 2nd 385 
overtone NIR measurements is less affected by changes in particle size compared to the 1st overtone. 386 
Furthermore, the peak-to-peak noise of the 2nd overtone NIR mixing profile increases with the 387 
particle size of the added compound. Li et al. (2007) showed the importance of a large beam size on 388 
the real-time determination of powder blend homogeneity by NIR spectroscopy.  389 
Several publications describe the possibility to quantify API and excipients during blending using NIR 390 
spectroscopy. El-Hagrasy et al. (2006c) developed several univariate and multivariate quantitative 391 
NIR models for prediction of blending endpoint. They found that linear regression, using a single 392 
wavelength, yielded optimum calibration and prediction results. Sulub et al. (2009) used a set of 21 393 
off-line static calibration samples for the development of a multivariate partial least squares (PLS) 394 
calibration model for in-line prediction of the API content during the blending process. Wu et al. 395 
(2009) quantified the constituent concentrations of both drug and excipients in powder blends using 396 
NIR spectroscopy. The authors concluded that the measurement uncertainties were higher for minor 397 
components in the powder formulations. Karanda et al. (2010) studied the difference between static 398 
and dynamic spectral acquisition. They found that dynamic spectral acquisition resulted in the most 399 
accurate predictions for all blend components. The authors further emphasize the importance of 400 
adopting appropriate and similar sampling strategies for both calibration and actual testing. 401 
El Hagrasy et al. (2006d) reported the use of NIR spectroscopy for monitoring of adequate lubricant 402 
(magnesium stearate, 0.5 – 9.0 %) mixing into pharmaceutical granules. Herewith, the significance of 403 
sensor location on the blender at different fill levels was evaluated. They found that different mixing 404 
endpoints were concluded dependent on the location of the NIR probe. 405 
3.2. Wet granulation 406 
High shear granulation and fluid bed granulation are the two most applied wet granulation 407 
techniques for the production process of pharmaceutical solids. During granulation, the powder 408 
particles are mixed with a granulation liquid leading to compound particles. Granulation aims at 409 
improving the material properties for further processing: improved flow properties, less demixing, 410 
better compressibility and less dust production.  411 
NIR and Raman spectroscopy have been mainly applied for the in-line monitoring of water content, 412 
particle size distribution, API solid state and endpoint of granulation processes. Furthermore, the 413 
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spectroscopic process fingerprints have been used to increase the understanding of the granulation 414 
process. 415 
List and Steffens (1996) demonstrated as first the use of NIR spectroscopy for the in-line solvent 416 
content determination during granulation. Rantanen et al. (2001a) showed that in-line NIR moisture 417 
determination during fluid bed granulation is possible based on the simultaneous detection of only 418 
four wavelengths. An entire NIR spectrum is not necessary for water determination, and often the 419 
use of only a few NIR wavelengths around the water band enables reliable and high-speed detection 420 
of moisture. In another study, Rantanen et al. (2000) evaluated the factors affecting in-line NIR 421 
moisture measurements with the above mentioned four-wavelength sensor. They found that particle 422 
size effects influence the spectral baseline and that the applied binder influences the NIR 423 
measurement. Watano et al. (1996) studied the effects of operational variables on the NIR 424 
measurement and found the effect of the granulation liquid flow rate and process air temperature to 425 
be significant. Several authors described the simultaneous determination of moisture content and 426 
particle size data using NIR spectroscopy. Frake et al. (1997) and  Findlay et al. (2005) demonstrated 427 
the simultaneous real-time monitoring of particle size and moisture content using NIR through a 428 
window into the bed of a fluidized bed granulator. This measurement setup avoids fouling and 429 
sticking of the wet material to the measurement device.  430 
 431 
Luukkonen et al. (2008) predicted granule and tablet quality properties such as particle size, porosity 432 
and hardness using in-line NIR data (i.e., the first NIR overtone band for water at 1460 nm) from a 433 
high-shear granulation process. Alcala et al. (2010) acquired NIR spectra through a glass window of a 434 
fluidizer during a wet granulation process. PCA of the NIR data allowed to distinguish between the 435 
different steps of the granulation process. A PLS model was developed allowing the prediction of 436 
moisture content, particle size distribution and bulk density. 437 
Li et al. (2005) used NIR spectroscopy for the quantitative monitoring of polymorph conversion of an 438 
active pharmaceutical ingredient during a wet granulation process. Wikström et al. (2005 and 2008) 439 
described the feasibility of Raman spectroscopy for in-line monitoring of the transformation of 440 
theophylline anhydrous to theophylline monohydrate during high shear wet granulation. Process 441 
induced transformations are important to be controlled as they can alter the API properties in the 442 
drug product, including therapeutic efficacy. They also found that process settings (e.g. mixing speed) 443 
influence the start and rate of transformation.  444 
Rantanen et al. (2001b) visualized a fluid-bed granulation process based on NIR spectroscopic 445 
multivariate process data. Self-organizing maps (SOMs) were used to visualize the process consisting 446 
of a number of process states. In another study, Rantanen et al. (2001c) showed that in-line NIR 447 
measurements provide information related to the amount of water throughout a fluid bed 448 
granulation process. This information combined with trend charts of the temperature difference 449 
between process inlet air and granules and the water content of process air enabled the control of 450 
water during fluid bed granulation and the analysis of the different granulation processes phases. 451 
Hence, in-line information on all granulation process steps was obtained. In 2005(b), Rantanen et al. 452 
monitored a high shear granulation process using NIR spectroscopy. In combination with PCA 453 
methods, three separate phases during the process could be elucidated. Information on the 454 
homogeneity of the formulation, the amount of water in the wet mass and the granule particle size 455 
was extracted from the NIR data. Hence, NIR allowed to determine the endpoints of the three 456 
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subphases of a high shear wet granulation process. Jorgensen et al. (2004a and 2004b) described in 457 
two manuscripts the visualization of a small-scale high-shear granulation process using in-line NIR 458 
spectroscopy and chemometrics. Physical (impeller torque and temperature) and chemical (NIR 459 
spectra) information were continuously monitored during granulation. Process vectors were created 460 
combining all data and describing all relevant information.  The visualization of the vectors was done 461 
using PCA and SOM. None of the individual measurement techniques were able to describe the state 462 
of the process alone.  463 
Tok et al. (2008) analyzed and compared the responses of NIR, focused beam reflectance 464 
measurements (FBRM) and acoustic emission measurements to monitor a pilot-scale fluidized bed 465 
granulation process. All three process analyzers were able to detect the three granulation phases 466 
(wetting and nucleation, consolidation and growth, breakage) to varying degrees of sensitivity. FBRM 467 
and NIR were susceptible to fouling on probe windows. Walker et al. (2007 and 2009) proposed a 468 
novel use of Raman spectroscopy, which allows in situ measurement of the composition of the 469 
material within the fluidized bed in three spatial dimensions and as function of time.  This was 470 
achieved by recording Raman spectra from specific volumes of space using a probe positioned within 471 
the fluidized bed on a long-travel x-y-z stage, hence providing 3D maps of the concentration and the 472 
chemical structure of the particles in motion in a fluidized bed within 10 seconds. 473 
3.3. Drying 474 
In 2000, Morris et al. presented a method to accelerate the fluid bed drying process relying on 475 
concepts of heat and mass transfer with real-time NIR monitoring of moisture. Critical NIR readings 476 
were used corresponding to the end of the evaporative cooling as temperature-independent 477 
endpoint. Räsänen et al. (2003) studied the dehydration behavior of theophylline granules using a 478 
novel multichamber microscale fluid bed dryer with a process air control unit and in-line NIR 479 
spectroscopy. The stepwise dehydration of materials was followed by the water content difference 480 
of inlet and outlet air temperature, the pressure difference over the bed, and in-line NIR 481 
spectroscopy. Green et al. (2005) examined different sampling configurations to improve the 482 
accuracy of the in-line residual moisture content determination during a fluid bed drying process. In-483 
line NIR data were collected (i) using the probe directly inserted into the fluid bed dryer such that 484 
measurements of dynamic flowing sample were collected, and (ii) using the NIR probe interfaced to a 485 
home-made sheath allowing static sample collection and utilizing an air purge to clean the probe 486 
face, thereby preventing probe fouling. This latter device was (iii) further modified to allow thieving 487 
of the actual sample being measured. They found that the latter sampling device allows collection of 488 
quality spectra in process systems and eases method development as NIR and reference 489 
measurements are performed on the same samples. Nieuwmeyer et al. (2007) demonstrated that 490 
NIR spectroscopy could be used for simultaneous water content determination (with errors 491 
comparable to the reference method) and median granule size. Romer et al. (2008a) proved that in-492 
line NIR measurements enable real-time monitoring of API (erythromycin dihydrate) phase 493 
transformations. Kogermann et al. (2008) demonstrated the ability of Raman and NIR spectroscopy 494 
for in-line quantitative solid state transformation during dehydration. Aaltonen et al. (2007) showed 495 
the complementarity of Raman and NIR spectroscopy for the quantitative in-line monitoring of solid-496 
state transitions during fluidization. NIR spectroscopy was particularly sensitive to water while 497 
Raman spectroscopy to crystal structure changes. Märk et al. (2010) implemented a continuous NIR 498 
14 
 
measuring setup to rapidly gain product assay, water content and residual solvent information during 499 
the fluid bed drying process in the production plant of an antibiotic substance. A bypass system 500 
outside the drier combined with a robust process probe proved to provide the best sampling system 501 
geometry. The spectrometer was equipped with an additional laboratory probe for simultaneous 502 
offline analysis. The process probe results were in agreement with the laboratory probe results. 503 
Hartung et al. (2010) showed that tablet characteristics after compression of granules are not only 504 
dependent on the residual moisture content of the granules but also on the moisture profiles during 505 
the entire fluid bed granulation process. The authors showed that 2 granule types with the same 506 
residual moisture content but with different moisture profiles during the entire fluid bed 507 
granulation/drying process are different. Granules with a low-moisture profile and a low residual 508 
moisture content have little water adsorbed on the surface of the granules, while for granules with a 509 
high-moisture profile and a likewise low residual moisture content the water had time to partially 510 
diffuse into the structure of the solid granule particles and to form liquid bridges. Peinado et al. 511 
(2010) developed a PLS model, based on NIR spectra and humidity determinations, allowing the in-512 
line prediction of the drying endpoint of a fluidized bed process. The in-process method was 513 
validated according to the ICHQ2(r1) guidelines. However, this guideline is not adopted to in-process 514 
methods developed and validated only with in-line samples in dynamic systems. Therefore, the 515 
authors propose a customized guideline addressing these challenges.  516 
3.4. Tableting 517 
Raman and NIR spectroscopy have been widely used to analyze (API quantification, solid state 518 
identification, process induced transformations) pharmaceutical tablets off-line in a fast, direct and 519 
non-destructive way as described by Räsänen and Sandler (2007) and Rantanen (2007). Therefore, 520 
there is a desire to use Raman and NIR spectroscopy in-line to evaluate tablets. The potential analysis 521 
speed of Raman and NIR spectroscopy should make it possible to largely increase the number of 522 
analyzed tablets (non-destructively) before release compared to the current situation where 523 
traditional off-line analysis methods (e.g. HPLC) are used. However, publications describing the in-line 524 
use of Raman and/or NIR spectroscopy and tool interfacing for tablet analysis are scarce. Johansson 525 
and Folestad (2003) discussed the potential use of Raman spectroscopy for monitoring tableting 526 
processes. Aaltonen et al. (2008) thoroughly reviewed to possibilities of using spatially offset Raman 527 
spectroscopy for the analysis of tablets. For this Raman spectroscopic analysis method, the Raman 528 
scattering is collected from a different sample portion than the irradiated sample fraction. Hence, 529 
fluorescence interference can be reduced as there is no emission from the sampled portion. Tabasi et 530 
al. (2008a) described the application of NIR spectroscopy to monitor a tablet manufacturing process. 531 
NIR spectroscopy in combination with multivariate modeling was used as a rapid and nondestructive 532 
technique for the prediction of content uniformity, compression force and crushing strength for 533 
orbifloxacin tablets. Cogdill et al. (2004) presented the development and validation of a PAT based 534 
NIR method for the on-line prediction of tablet hardness and API content. 535 
3.5. Coating 536 
Kirsch and Drennen (1996) and Andersson et al. (1999) demonstrated the applicability of at-line NIR 537 
spectroscopy as an accurate, rapid and non-destructive tool for the determination of the amount of 538 
polymer film on tablets. Andersson et al. (2000) provided a first in-line study in which NIR 539 
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spectroscopy was used for the quantitative analysis of film coating on pellets in a fluidized bed 540 
process. Measurements were done utilizing a diffuse reflectance fiber-optic probe positioned inside a 541 
fluidized bed process vessel. The authors thoroughly describe the probe interfacing in the fluid bed. 542 
Besides the coating thickness determination with high precision, also an estimate could be obtained 543 
of the coating thickness variation. A similar study was done by Perez-Ramos et al. (2005) and Romer 544 
et al. (2008b) in a pan coater and rotating plate coating system, respectively. These authors also 545 
emphasize that a sufficiently fast sampling rate is needed and that the fiber optic probe or sensor has 546 
to be optimized for the monitoring purpose. Lee et al. (2010) proposed new approaches to develop a 547 
reasonable dynamic calibration model for the in-line monitoring of film thickness of pharmaceutical 548 
tablets processed in a fluid-bed coater. Tabasi et al. (2008 b and c) published two papers in which the 549 
applicability of NIR spectroscopy for the in-line monitoring of a coating process and its subsequent 550 
curing process of a pharmaceutical sustained release product has been proven. Besides coating 551 
thickness, NIR spectroscopy is able to detect polymorphic changes during coating processes (Kamada 552 
et al., 2009). Raman spectroscopy has also been proved as an adequate tool for coating evaluation. 553 
Romero-Torres et al. (2005) suggested the feasibility of Raman spectrometry to examine the 554 
variability of tablet coatings. A Raman probe was used that can operate with a revolving laser focus 555 
to average content and coating non-uniformity. Furthermore, the authors describe adequate 556 
preprocessing techniques that emphasize spectral changes while minimizing the effects of 557 
background light scattering and fluorescence. In another study, the same authors used Raman 558 
spectroscopy to quantify tablet coating thickness in the presence of a fluorescent ingredient in the 559 
coating formulation (Romero-Torres et al., 2006). In a very recent study, Muller et al. (2010) used 560 
Raman spectroscopy for the in-line monitoring of an active coating process. Active coating is a film 561 
coating process where the API is included in the coating layer. Raman spectroscopy was able to show 562 
in-line when the API quantity in the coating was as desired, hence suggesting the endpoint of the pan 563 
coating process. To protect the probe against dust, compressed air was blown through an iron pipe, 564 
which was attached in front of the probe. 565 
3.6. Pelletization 566 
The number of publications describing the use of Raman and NIR spectroscopy for the in-process 567 
analysis of pelletization processes is low.  Sandler et al. (2005) used Raman and NIR spectroscopy at-568 
line to increase the understanding of the solid-state behavior of theophylline and nitrofurantoin 569 
formulations during pelletization. NIR gave valuable information on the water behavior during 570 
processing, but did not allow to detect the hydrate formation in the formulations because of the 571 
saturation of the water signal. However, Raman spectroscopy was able to see the hydration and 572 
dehydration phenomena during the process proving the complementarity of Raman and NIR 573 
spectroscopy. In another study, at-line NIR spectroscopy was applied to understand the process 574 
induced transformations of erythromycin dehydrate during pellet production (Römer et al., 2007). 575 
3.7. Freeze-drying 576 
Romero-Torres et al. (2007) and De Beer et al. (2007) described the use of Raman spectroscopy for 577 
the fast, non-invasive in-line monitoring of a simple mannitol solution freeze-drying process. 578 
Furthermore, De Beer et al. (2009a and 2009b) compared the simultaneous use of Raman and NIR 579 
spectroscopy for the in-line monitoring of lyophilization processes. Raman spectroscopy proved to be 580 
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an excellent tool for crystallization and polymorphic transformation monitoring during the complete 581 
freeze-drying process. As water and ice produce weak signals in Raman spectra, Raman spectroscopy 582 
provides clear product solid state information during the freezing phase, primary drying phase and 583 
secondary drying phase. In contrast, NIR spectroscopy is suited for the in-line monitoring of the 584 
water and ice behavior during freeze-drying. As ice produces huge signals in NIR spectra, NIR 585 
spectroscopy is unable to provide detailed solid state information during the freezing and primary 586 
drying phase. Brülls et al. (2003) showed as first the use of NIR spectroscopy for the in-line 587 
monitoring of a freeze-drying. However, measurements were done invasively in this study. The main 588 
disadvantages of Raman and NIR spectroscopy for in-process freeze-drying monitoring is that only 1 589 
vial can be monitored in the current set-up. Both process analyzers showed to be interesting R&D 590 
tools for lab-scale freeze-dryers, but the applicability in large production scale freeze-dryers is still far 591 
away. In an another study, de Waard et al. (2010) showed the applicability of in-line Raman 592 
spectroscopy for controlled crystallization of the lipophilic drug fenofibrate during freeze-drying. Off-593 
line studies suggest that Raman and NIR spectroscopy will be able to monitor in-line secondary 594 
protein structure changes during lyophilization. 595 
3.8. Continuous production 596 
Nowadays, there is a major interest within the pharmaceutical industry to move from traditional 597 
batch processes towards continuous processes. Several production machine suppliers recently 598 
proposed their first versions of continuous production lines: e.g. the ConsiGmaTM system from GEA, 599 
the EASY FLOW® system from Böhle. The challenge now is the find out if the critical process aspects 600 
from the traditional batch processes above can be monitored and controlled in-line in their 601 
corresponding continuous production processes. We did not find publications describing the in-line 602 
use of Raman and NIR spectroscopy for the in-line monitoring of continuous blending, continuous 603 
granulation, continuous drying and continuous coating processes. 604 
Saerens et al. (2010) recently showed the Raman spectroscopic in-line monitoring of a (continuous) 605 
pharmaceutical hot-melt extrusion process. Raman spectroscopy allowed the in-line API 606 
quantification as well as the polymer and API solid state characterization during processing. Solid 607 
solutions showed Raman band broadening compared to solid dispersions. Furthermore, Raman peak 608 
shifts appeared in the spectra of solid dispersions and solid solutions compared to the physical 609 
mixtures, suggesting interactions (hydrogen bonds) between polymer and API. 610 
611 
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4. Conclusions 612 
Raman and NIR spectroscopy have been widely used for the in-process monitoring of several batch 613 
unit operations during the production of pharmaceutical solid dosage forms. Both PAT tools are 614 
complementary and able to supply physical and chemical critical product and process information 615 
during processing, herewith increasing the process understanding. Special attention should be paid 616 
to the interfacing of probes into process streams (Figure 6). A next step within the PAT framework, is 617 
the use the real-time obtained critical process and product information from the process analyzers, 618 
based on feed-forward and feed-back loops, and steer and guide processes towards their desired 619 
state. Finally, Raman and NIR spectroscopy will certainly play a key role in the real-time monitoring 620 
and control of continuous pharmaceutical production processes, which is currently of major interest 621 
within the pharmaceutical industry. 622 
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Table 1: Applications of Raman and/or NIR spectroscopy for the in-process monitoring of pharmaceutical production processes. Some boxes in the table are 909 
left open as specified information was not given by the reference. The table is subdivided per described process. Within each subdivision the examples are 910 
ordered by year of publication. 911 
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Application + formulation Raman/NIR In-process interfacing Monitored critical 
process information 
Evaluated challenges Data-analyis 
method 
Spectral preprocessing 
method 
reference 
1. Blending        
In-line monitoring of powder blending NIR Invasive Homogeneity real-time control MBSD SNV and detrending 
transformation 
Hailey et al., 1996 
In-line monitoring of powder blending NIR Invasive Homogeneity 1. Spectral 
preprocessing 
evaluation 
2. evaluation of 
different algorithms for 
blending endpoint 
detection 
MBSD 
Dissimilarity 
calculations 
Principal 
component analysis 
Detrending  
SNV 
Second derivatives 
Combined detrending 
and SNV 
Sekulic et al., 1998 
In-line monitoring of powder blending NIR Non-invasive Homogeneity Multiple sampling 
points in the blender 
MBSD variant SNV 
MSC 
2nd derivatives 
El-Hagrasy et al., 2001 
In-line endpoint detection of the 
blending of a binary pellet mixture 
Raman Non-contact probe in front of 
glass window in mixing bowl 
Blend homogeneity  MSD Baseline correction 
Vector normalization 
Vergote et al., 2004 
In-line homogeneity detection Raman Non-contact probe Blend homogeneity Raman sampling optics PCA SNV Wikström et al., 2005 
In-line monitoring of low dose blend 
uniformity 
Raman an immersion probe was 
inserted into the V-blender 
through the I-bar port 
Blend homogeneity API present in low dose 
(1%) 
1. univariate: peak 
intensity vs. blend 
time 
2. Mahalanobis 
distance method 
SNV Hausman et al., 2005 
In-line monitoring a an aqueous 
suspension homogenization process 
Raman Invasive measurement via an 
immersion probe 
1. homogeneity 
2. API quantification 
aqueous environment 1. conformity index 
2. PCR 
Pearson’s baseline 
correction 
De Beer et al., 2006 
In-line monitoring of powder blending NIR Non-invasive Homogeneity Evaluation of chemical 
and physical blend 
properties in NIR 
spectra 
MBSD variant SNV 
MSC 
2nd derivatives 
El-Hagrasy et al., 2006a 
In-line monitoring of powder blending NIR Non-invasive Homogeneity Prediction of blend 
homogeneity of 
independent blend 
samples manufactured 
under different 
processing conditions 
SIMCA 
PC-MBEST 
2nd derivatives El-Hagrasy et al., 2006b 
In-line monitoring of powder blending NIR Non-invasive Homogeneity and API 
content 
Evaluation of univariate 
and multivariate 
quantification mehtods 
1. PCR 
2. PLS 
3. MLR 
 4. Univariate 
2nd derivatives El-Hagrasy et al., 2006c 
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calibration 
In-line monitoring of powder blending NIR Non-invasive Homogeneity Homogeneous mixing 
of lubricants into 
granules 
PLS SNV + 2nd derivatives El-Hagrasy et al., 2006d 
In-line monitoring of post-blending NIR Invasive segregation In-line monitoring of 
segregation after 
blending and during 
voiding 
 Spectral subtraction Barajas et al., 2007 
In-line monitoring of powder blending NIR  Non-invasive Homogeneity Effect of beam size PLS Savitzky-Golay 1st 
derivatives 
Li et al., 2007 
In-line endpoint detection of the 
blending of a multicomponent powder 
mixture 
Raman Invasive monitoring via an 
immersion probe 
Blend homogeneity  SIMCA Offset correction and 
normalization 
De Beer et al., 2008 
In-line monitoring of powder blending NIR Non-invasive Homogeneity Effect of particle size   Bellamy et al., 2008 
In-line monitoring of powder blending NIR Non-invasive Homogeneity Multiple sampling 
points in the blender 
PLS + root mean 
square from 
nominal value 
Savitzky-Golay 
smoothing and 2nd 
derivative 
Shi et al., 2008 
In-line monitoring of powder blending NIR  Homogeneity  Accurate blending 
endpoint determination 
Hidden Markov 
model 
 Zhang et al., 2009 
In-line monitoring of powder blending NIR Non-invasive In-line API 
quantification 
In-line quantification 
method using an off-
line external calibration 
approach 
PLS SNV + 2nd derivative 
Savitzky-Golay 
Sulub et al., 2009 
In-line monitoring of powder blending NIR Non-invasive In-line quantifications In-line quantification of 
API and excipients 
simultaneously 
PLS 
PCR 
MLR 
Savitzky-Golay 1st 
derivatives 
Wu et al., 2009 
In-line monitoring of powder blending NIR Non-invasive Homogeneity Static versus dynamic 
sampling 
PLS SNV Karanda et al., 2010 
2. granulation        
In-line monitoring of fluid bed 
granulation 
NIR  Moisture content Evaluation of particle 
size and binder effect 
 2nd derivatives Rantanen et al., 2000 
In-line monitoring of fluid bed 
granulation 
NIR  Moisture content Moisture 
determination based on 
four wavelengths 
ANN  Rantanen et al., 2001a 
In-line monitoring of fluid bed 
granulation 
NIR + other 
non-
spectroscopic 
data 
invasive Visualization of fluid-
bed granulation 
 SOM  Rantanen et al., 2001b 
In-line monitoring of fluid bed NIR + other Invasive Moisture  Design of Baseline correction + Rantanen et al., 2001c 
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granulation non-
spectroscopic 
data 
determination experiments normalization 
In-line monitoring of high shear 
granulation 
NIR + non-
spectroscopic 
process 
information 
At-line through glass vials Visualization of a wet 
granulation process 
SOM versus PCA PCA + SOM 2nd derivative spectra 
with Savitzky-Golay 
smoothing 
Jorgensen et al., 2004a 
and 2004b 
In-line monitoring of high shear 
granulation 
NIR  Quantitative 
monitoring of API 
polymorph 
conversion 
Solid state changes 
during granulation 
MLR 1st derivatives 
2nd derivatives 
4th derivatives 
Li et al., 2005 
In-line monitoring of fluid bed 
granulation 
NIR Non-invasive Moisture + particle 
size 
Granulation endpoint 
determination 
Weighted linear 
combinations of 
individual 
reflectance values 
 Findlay et al., 2005 
In-line monitoring of high shear 
granulation 
Raman/NIR Invasive measurements using 
immersion probe just above 
impeller to reduce the risk of 
sample adhesion 
Monitoring of 
hydrate formation 
   Wikström et al., 2005 
In-line monitoring of high shear 
granulation 
NIR through aperture in the plastic 
cover of the granulator. 
aperture was covered with 
glass in order to avoid coating 
the collection lens and light 
source with dust. Adhesion of 
powder to the glass was 
avoided by rotating the glass 
during processing. 
Endpoint detection of 
granulation 
subphases 
 PCA SNV Rantanen et al., 2005b 
In-line monitoring of high shear 
granulation 
NIR invasive Process fingerprint Prediction of granule 
and tablet properties 
Univariate, PLS and 
multiway PLS 
 Luukkonen et al., 2008 
In-line monitoring of fluid bed 
granulation 
NIR + FBRM + 
physical 
acoustic 
NIR + FBRM  invasive 
Acoustic  non-invasive 
Endpoint detection of 
granulation 
subphases 
FBRM and NIR 
susceptible to fouling 
univariate  Tok et al., 2008 
In-line monitoring of fluid bed 
granulation 
Raman Raman probe positioned in 
fluid bed on a long-travel x-y-z 
stage 
3-D mapping during 
fluid bed granulation 
Multi-point data 
collection at  
univariate  Walker et al., 2009 
In-line monitoring of fluid bed 
granulation 
NIR Non-invasive through glass 
window 
Moisture content, 
particle size 
distribution and bulk 
 PLS SNV 
1st derivatives 
2nd derivatives 
Alcala et al.,2010 
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density 
3. drying        
In-line monitoring of fluid bed drying NIR Non-invasive through window Drying endpoint Accelerated drying 
based on NIR 
measurements 
  Morris et al., 2000 
In-line monitoring of fluid bed drying NIR Multi-channel NIR 
spectroscopy + non-
spectroscopic data 
Water content Dehydration behavior 
of materials 
Univariate Normalization Räsänen et al., 2003 
In-line monitoring of fluid bed drying NIR invasive Moisture content Evaluation of sampling 
effects on method 
accuracy 
PLS SNV + Savitzky-Golay 
2nd derivatives 
Green et al., 2005 
In-line monitoring of fluid bed drying NIR invasive Water content + 
median granule size 
 PCA 
PLS 
SNV + Savitzky-Golay 1st 
derivatives 
Nieuwmeyer et al., 
2007 
In-line monitoring of fluid bed drying NIR and 
Raman 
Non-invasive API phase 
transformations 
during drying 
Raman and NIR are 
complementary 
PLS SNV Aaltonen et al., 2007 
In-line monitoring of fluid bed drying NIR Non-invasive API phase 
transformations 
during drying 
 PCA Savitzky-Golay first 
derivative smoothing 
+ SNV 
Romer et al., 2008a 
In-line monitoring of fluid bed drying NIR and 
Raman 
Non-invasive API phase 
transformations 
during drying 
quantification PLS SNV Kogermann et al., 2008 
monitoring of fluid bed drying NIR On-line using bypass system Product assay, water 
content, residual 
solvent 
On-line versus off-line univariate SNV, MSC, 1st and 2nd 
derivatives, straight 
line subtraction 
Märk et al., 2010 
In-line monitoring of fluid bed drying NIR Invasive (design makes product 
movement cleaning the NIR 
window) 
Drying endpoint Difference between 
residual moisture and 
moisture profile during 
drying 
  Hartung et al., 2010 
In-line monitoring of fluid bed drying NIR invasive Drying endpoint An adapted ICHQ2(r1) 
guideline was proposed 
which is suitable for in-
process methods 
developed and 
validated only with in-
line samples in dynamic 
systems.  
PLS SNV Peinado et al., 2010 
4. tablet manufacturing        
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Monitoring of tablet manufacturing NIR Non-invasive Content uniformity, 
compression force, 
crushing strength 
Use of rapid content 
NIR analyzer 
PLS SNV + MSC + Savitzky-
Golay 1st derivatives 
Tabasi et al., 2008 
5. coating        
Monitoring of fluid bed coating NIR At-line Determination of 
amount of polymer 
coat applied to tablet 
cores 
 PCA MSC 
2nd derivatives 
Kirsch and Drennen, 
1996 
Monitoring of coating (rotating drum) NIR At-line Determination of 
amount of tablet 
coating 
Estimation of maximum 
depth in coating 
material 
PCA 
PLS 
MSC Andersson et al., 1999 
In-line monitoring of fluidized bed 
coating 
NIR Invasive. To secure 
representative sampling during 
processing, a sample collector 
that was emptied by 
compressed air was used inside 
the vessel. The sapphire 
window at the probe tip 
constituted the interface of the 
probe to samples in the 
process vessel. 
Quantitative analysis 
of film coating 
General aspects of in-
line NIR on solids and 
multivariate batch 
calibration are 
discussed. 
PLS SNV 
MSC  
2nd derivatives 
Andersson et al., 2000 
In-line monitoring of pan coating NIR Non-invasive. To avoid coating 
droplets from damaging the 
sensor, the top and sides of the 
sensor were protected with a 
plexiglass box with a nitrogen 
purge 
Quantitative analysis 
of film coating 
Real-time endpoint 
detection of coating 
process 
Univariate 2nd derivatives Perez-Ramos et al., 
2005 
Monitoring of pan coating Raman At-line Determination of coat 
thickness 
Tablet-to-tablet coating 
variability 
PLS SNV 
MSC 
2nd derivatives Savitzky-
Golay smoothing 
Romero-Torres et al., 
2005 
Monitoring of pan coating Raman At-line Determination of coat 
thickness 
Presence of strong 
fluorescent 
interference 
Univariate + 
multivariate 
SNV 
MSC 
2nd derivatives Savitzky-
Golay smoothing 
Romero-Torres et al., 
2006 
In-line monitoring of rotating plate 
coating system 
NIR Non-invasive Prediction of coating 
thickness 
 PLS SNV + Savitzky-Golay 
smoothing 
Romer et al., 2008 
monitoring of pan coating NIR At-line Determination of coat 
thickness and curing 
curing PCA 
PLS 
SNV + 2nd derivatives Tabasi et al., 2008a and 
b 
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monitoring of coating NIR At-line Determination of 
polymorphic changes 
during coating 
quantitative Univariate 2nd derivatives Kamada et al., 2009 
In-line monitoring of fluid bed coating  NIR invasive Prediction of film 
thickness 
Dynamic calibration PCA 
PLS 
MSC Lee et al., 2010 
In-line monitoring of pan coating Raman Non-invasive. To protect the 
probe against dust, 
compressed air was blown 
through an iron pipe, which 
was attached in front of the 
probe. 
Quantitative 
determination of API 
in coat + endpoint 
determination 
Active coating process PLS SNV Muller et al., 2010 
6. pelletisation        
Monitoring of pelletisation Raman/NIR At-line API solid-state 
changes 
Complementary Raman 
and NIR 
univariate 2nd derivatives Sandler et al., 2005 
Monitoring of pelletisation NIR At-line Process-induced 
transformations 
 univariate 2nd derivatives + 
Savitzky-Golay 
smoothing 
Römer et al., 2007 
7. freeze-drying        
In-line monitoring of lyophilisation Raman Non-contact phat probe 
through quartz window in 
freeze-drier door 
Mannitol phase 
behavior during 
freeze-drying 
 PCA  Romero-Torres et al., 
2007 
In-line monitoring of lyophilisation Raman/NIR Non-contact probes built in the 
freeze-drier chamber 
Product monitoring 
and process phase 
endpoint 
determination 
Raman versus NIR PCA Pearson’s baseline 
correction 
De Beer et al., 2007 
De Beer et al., 2009a 
De Beer et al., 2009b 
In-line monitoring of lyophilisation Raman Non-contact probe built in the 
freeze-drier chamber 
In-line product 
behavior monitoring 
Controlled 
crystallization of 
product 
PCA Pearson’s baseline 
correction 
de Waard et al., 2010 
8. hot-melt extrusion        
In-line monitoring of hot-melt extrusion Raman Contact probe built in the die In-line product 
behavior monitoring 
API quantification + 
polymer/drug 
interactions 
PCA 
PLS 
Savitzky-Golay and SNV Saerens et al., 2010 
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Abbreviations: 913 
- ANN  artificial neural networks 914 
- API  active pharmaceutical ingredient 915 
- MBSD  moving block standard deviation 916 
- MLR  multiple linear regression 917 
- MSC  multiplicative scatter correction 918 
- MSD  mean square of differences 919 
- NIR  near infrared 920 
- PCA  principal component analysis 921 
- PC-MBEST Principal Component Modified Bootstrap Error-adjusted Single-sample 922 
Technique 923 
- PCR  principal component regression 924 
- PLS  partial least squares 925 
- SIMCA  Soft Independent Modelling of Class Analogy 926 
- SNV  standard normal variate 927 
- SOM  self-organizing maps 928 
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Figure 2a: Vibration states of diatomic molecule  931 
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Figure 6: Factors affecting the interfacing of Raman and NIR spectroscopy into process streams 937 
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